Sign in

Mark Wildgust

@mawildgust.bsky.social
330 followers 151 following 23 posts

VP of Oncology Global Medical Affairs at Johnson & Johnson focused on bringing new treatment options for patients with cancer. Posts shared are my own. 🇬🇧🇺🇸🏳️‍🌈

PostsRepliesMedia
Reposted by Mark Wildgust
Nature Portfolio @natureportfolio.nature.com · 03/02/2025
A Comment article in Nature Medicine argues that clinical research should recruit participants from LGBTQIA+ populations, which requires specific actions and policies to create affirming and welcoming environments. go.nature.com/3WILuQi 🧪
Historically underrepresented in clinical studies, LGBTQIA+ people face systemic barriers that perpetuate health inequities and hinder the advancement of medical knowledge tailored to their needs.
07924
Mark Wildgust @mawildgust.bsky.social · 09/02/2025
Our mission @J&J is to understand how our medicines work in all pts. I’m honored to have contributed to this ground breaking paper in @naturemedicine.bsky.social identifying a roadmap for inclusion of #LGBTQIA+ individuals. @fenwayhealth.bsky.social #MyCompany www.nature.com/articles/s41...
nature.com
A roadmap for engagement and inclusion of LGBTQIA+ people in clinical research - Nature Medicine
Clinical research should recruit participants from LGBTQIA+ populations, and this requires specific actions and policies to create affirming and welcoming environments.
281
Mark Wildgust @mawildgust.bsky.social · 26/01/2025
Excited to share our #SKIPPirr study was just published. Great job everyone involved in this study. #EGFR #NSCLC #PatientFocus #MyCompany www.sciencedirect.com/science/arti...
sciencedirect.com
Brief Report: Preventing Infusion-related Reactions With Intravenous Amivantamab: Results From SKIPPirr, a Phase 2 Study
Amivantamab, an EGFR–MET bispecific antibody, is approved for multiple indications in EGFR-mutated advanced non-small cell lung cancer (NSCLC) as mono…
120
Mark Wildgust @mawildgust.bsky.social · 08/12/2024
Great to speak at the @statnews.bsky.social panel Stat@ash on our goals in #hematology driving towards transforming outcomes in cancer. #MyCompany
180
Mark Wildgust @mawildgust.bsky.social · 08/12/2024
Great to see the discussion by @statnews.bsky.social on #Sicklecell here #ASH24 at their STAT@ASH event. Great moderating by @adamfeuerstein.bsky.social
060
Mark Wildgust @mawildgust.bsky.social · 08/12/2024
Excited to be speaking on the @statnews.bsky.social panel this evening at #ASH24. Speaking on the innovations in hematology that Johnson & Johnson Innovative Medicine are leading and pioneering. #MyCompany
040
Mark Wildgust @mawildgust.bsky.social · 07/12/2024
Great to see the Bleximenib data being presented here at #ASH24! More progress is needed in AML! #MyCompany
051
Mark Wildgust @mawildgust.bsky.social · 06/12/2024
Love being at #ASH24. Finding time to grab something to east isn’t easy! But when you find a snack in a meeting room …. #Hungry
media.tenor.com
a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael
ALT: a cookie monster is sitting on a kitchen counter next to a measuring cup that says rachael
050
Mark Wildgust @mawildgust.bsky.social · 05/12/2024
Heading to #ASH24. Didn’t think there was such a thing as a red eye from the East coast to the West but will land at 2:30am EST in San Diego. 🥱😴.
170
Mark Wildgust @mawildgust.bsky.social · 26/11/2024
As I leave Hong Kong to head home I’m reflecting on a great visit. Strengthening friendships, building new friendships, leading with science and as my friend @tonymokum.bsky.social says over good food!
040
Mark Wildgust @mawildgust.bsky.social · 24/11/2024
Amazing dinner with Tony and some faculty at the #IOHK24 meeting. Amazing restaurant on Lamma Island.
250
Mark Wildgust @mawildgust.bsky.social · 24/11/2024
Come and join the J&J sponsored satellite symposium here at #IOHK24. Great speaker line up. #MyCompany
010
Mark Wildgust @mawildgust.bsky.social · 24/11/2024
Terrific key note presentation by Tony Mok here at #IOHK24 on immunotherapy in #LungCancer.
010
Mark Wildgust @mawildgust.bsky.social · 23/11/2024
Great to catch up with @antoniopassaro.bsky.social while at the #IOHK24 meeting.
010
Mark Wildgust @mawildgust.bsky.social · 23/11/2024
Spectacular talk by Prof Maximilian Diehn on ctDNA and MRD in #LungCancer here at #IOHK24!
020
Mark Wildgust @mawildgust.bsky.social · 23/11/2024
Looking forward to @solangepeters.bsky.social presentation here at #IOHK24!
041
Mark Wildgust @mawildgust.bsky.social · 23/11/2024
Great to be here in #HongKong at #IOHK24 for a terrific meeting. Opening remarks from Tony Mok!
040
Mark Wildgust @mawildgust.bsky.social · 22/11/2024
In Hong Kong for the Immuno-Oncology meeting. Also got to meet a famous local HK resident/TV star!
110
Mark Wildgust @mawildgust.bsky.social · 22/11/2024
Heading to #ASH24? Love to connect and reconnect with anyone going. Johnson & Johnson Innovative Medicine team will be there in full force, presenting new data across our hematology portfolio. #Mycompany
010
Mark Wildgust @mawildgust.bsky.social · 22/11/2024
Happy to join the Bluesky community.
140